Heyndrickxia coagulans or Bacillus coagulans: understanding the name change
Taxonomy of this spore-forming probiotic and why documents may use Heyndrickxia coagulans, Weizmannia coagulans or the former Bacillus coagulans.
Why spore-forming probiotics offer formulation advantages
How resistant endospores help B. coagulans tolerate heat, acid and gastrointestinal transit for shelf stability and intestinal delivery.
How to formulate Bacospore® into supplements and functional foods
A practical guide covering viable-count calculations, moisture control and processing considerations.
Understanding viable spore count in probiotic ingredients
Why CFU/g, overage, finished-product shelf life and storage conditions are critical when selecting a spore-forming probiotic.
Bacospore® and gastrointestinal health: what the preclinical evidence shows
Gastric mucosal protection, diarrhoea models and possible mechanisms involving barrier integrity, microbial balance and inflammatory modulation.
Cholesterol-lowering activity of Bacospore® explained
In-vitro evidence on cholesterol assimilation, bile interactions and BSH-associated mechanisms, and the distinction from human outcomes.